Age-impaired remyelination is associated with dysregulated microglial transitions

年龄相关的髓鞘再生障碍与小胶质细胞转化失调有关。

阅读:10
作者:Sameera Zia ,Marianela E Traetta ,Charbel S Baaklini ,Brady P Hammond ,Rebecca K John ,Katherine M Souter ,Niels Meijns ,Larry K A Afun ,Sharmistha Panda ,Fernando González Ibáñez ,Mena K Burr ,Eva Dhupia ,Abhisha M Rathod ,Andre O Faria ,Dhruvish Zaveri ,Sowmya Challa ,Eugene Hahn ,Sohrab B Manesh ,Kelly V Lee ,Madelene F S Ho ,Timothy N Friedman ,Aislinn D Maguire ,Arina Pang ,Olivia Farkas ,Bożena Szulc ,Luiz Tenorio ,Diya Vyas ,Olivia R La Caprara ,Wolfram Tetzlaff ,Sarthak Sinha ,Gregory J Duncan ,Anastassia Voronova ,Bradley J Kerr ,Marie-Eve Tremblay ,Jeff Biernaskie ,Geert Schenk ,Jason R Plemel

Abstract

Multiple sclerosis (MS) is a chronic, inflammatory condition characterized by neurodegeneration and lost myelin, or demyelination. This lost myelin may be regenerated in people with MS through a process called remyelination, that is prone to failure and is impaired with age. Remyelination is facilitated by microglia but our understanding of the microglial response during remyelination is incomplete. Here, we profile the microglial response during remyelination in the lysolecithin mouse model using single-cell RNA sequencing and find several distinct microglial states during the early stages of remyelination that coalesce into a resolved state defined by the presence of myelin transcripts, a state also present in MS brains. We also observe a delay in the appearance of several microglial states with age, in concordance with delayed remyelination. This multi-faceted microglial response during efficient remyelination provides the basis of multi-faceted microglia-specific targets for future MS therapies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。